P. Barnes

Pulmonary and Respiratory Medicine · The Lancet · 2000–2020

A researcher in the Science corpus: 19 papers; trusts 22 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Pulmonary and Respiratory Medicine — 140 citations into it
• Physiology — 90 citations into it; #1,123 of 2,276 by trust here, #624 by citations
• Immunology — 50 citations into it; #1,040 of 2,160 by trust here, #1,610 by citations
• Sociology and Political Science — 37 citations into it
• Molecular Biology — 36 citations into it; #10,516 of 17,773 by trust here, #10,506 by citations
• Emergency Medical Services — 23 citations into it; #190 of 207 by trust here, #84 by citations
• Oncology — 19 citations into it; #1,008 of 1,698 by trust here, #1,267 by citations
• Endocrinology, Diabetes and Metabolism — 12 citations into it

Whom P. Barnes trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Sally E. Wenzel
2. Ian M. Adcock
3. I. Stamenkovic
4. A. Proudfoot
5. Bartolome Celli
6. T. Seemungal
7. David M. Mannino
8. J. Cidlowski
9. H. Forman
10. Valerie Fadok

Who trusts P. Barnes overall

1. P. Kirkham
2. S. Galli
3. J. Fahy
4. B. P. Ashburner
5. D. Prockop
6. George M. Slavich
7. H. Hammad
8. Ian M. Adcock

Papers from P. Barnes's perspective

Ordered by how strongly the researchers P. Barnes trusts endorse each paper. Same corpus, a different order for every researcher.

1. Evidence of a role of tumor necrosis factor alpha in refractory asthma. (New England Journal of Medicine)
2. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids (Thorax)
3. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. (American Journal of Respiratory and Critical Care Medicine)
4. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. (American Journal of Respiratory and Critical Care Medicine)
5. Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
6. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells (Nature)
7. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. (European Respiratory Journal)
8. Chronic obstructive pulmonary disease. (Clinical evidence)
9. Chronic obstructive pulmonary disease: current burden and future projections (European Respiratory Journal)
10. Global burden of COPD: risk factors, prevalence, and future trends. (The Lancet)

Their papers

• Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 (2000) — 763 citations
• Exhaled markers of pulmonary disease. (2001) — 863 citations
• Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. (2000) — 1,909 citations
• Sex and gender: modifiers of health, disease, and medicine (2020) — 1,477 citations
• Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. (2016) — 1,489 citations
• Neural control of human airways in health and disease. (2015) — 640 citations
• Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. (2013) — 681 citations
• Oxidative stress in COPD. (2013) — 694 citations
• Chronic obstructive pulmonary disease in non-smokers (2009) — 737 citations
• Glucocorticoid resistance in inflammatory diseases. (2009) — 993 citations
• Immunology of asthma and chronic obstructive pulmonary disease (2008) — 1,478 citations
• The cytokine network in asthma and chronic obstructive pulmonary disease. (2008) — 964 citations
• Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. (2008) — 636 citations
• Exacerbations of chronic obstructive pulmonary disease (2007) — 850 citations
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) — 13,352 citations
• How corticosteroids control inflammation: Quintiles Prize Lecture 2005 (2006) — 815 citations
• Isoprostanes: markers and mediators of oxidative stress (2004) — 782 citations
• Mediators of Chronic Obstructive Pulmonary Disease (2004) — 730 citations
• Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. (2001) — 698 citations